跳至主要内容
临床试验/IRCT2015030921397N1
IRCT2015030921397N1已完成2 期

Assessment of effect of intravenous ketamine in suicidal ideas among patients with major depressive disorder in comparison with control group

Vice chancellor for research, Hormozgan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • depression diagnosis due to DSM IV criteria; benign major depression episode; suicidal thoughts; no use of antidepression drugs in last month; age above 18
  • Exclusion criteria: bipolar disorder type 1 & 2; cyclothymia; psychosis having other disorder of 1or 2 axis simultaneusly; drug addiction or withdrawal; medical disease which causes depression; pregnancy; breast feeding; cardiovascular disease history

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Hormozgan University of Medical Sciences

相似试验